5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Oncology Today with Dr Neil Love

EpisodeNov 25, 202410m

5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Oncology Today with Dr Neil Love

EpisodeNov 25, 202410m

Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral selective estrogen receptor degraders for ER-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.

Top comments

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

www.researchtopractice.com

Switch to the Fountain App

Open in Fountain